Citalopram
Celexa
Also known as: Cordarone, Pacerone
Extreme QTc prolongation. Amiodarone has half-life of 40-55 DAYS. Additive QTc with ibogaine is potentially fatal.
Severity
Contraindicated
Mechanism
QT-interval prolongation
Protocol Status
Generally not eligible until alternative management is established
Restart Delay
Physician discretion
What "Contraindicated" Means
Absolute prohibition without an enforced washout. Treatment cannot proceed safely until the medication has been cleared from the body for the protocol's required interval.
Clinical Action
CANNOT safely wash out — half-life too long. Patient may be ineligible for ibogaine treatment.
Where the Washout Happens
Generally not eligible until alternative management is established
Pharmacology (e.g., ultra-long half-life) makes safe washout impractical within any reasonable treatment window. Treatment generally cannot proceed until cardiology or the prescribing physician has established alternative management.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes — a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.
Same Mechanism
Same Severity Tier
Serotonergic activity (serotonin syndrome)
Prozac, Sarafem
Serotonergic activity (serotonin syndrome)
Zoloft
Serotonergic activity (serotonin syndrome)
Paxil, Pexeva
Serotonergic activity (serotonin syndrome)
Luvox
Serotonergic activity (serotonin syndrome)
Trintellix, Brintellix
Serotonergic activity (serotonin syndrome)
Viibryd
Common Questions
Contraindicated. Extreme QTc prolongation. Amiodarone has half-life of 40-55 DAYS. Additive QTc with ibogaine is potentially fatal. CANNOT safely wash out — half-life too long. Patient may be ineligible for ibogaine treatment.
Generally not eligible until alternative management is established. Pharmacology (e.g., ultra-long half-life) makes safe washout impractical within any reasonable treatment window. Treatment generally cannot proceed until cardiology or the prescribing physician has established alternative management.
QT-interval prolongation. Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes — a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Amiodarone — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 103 medications in the A–Z directory.